HI
| Investor | Firm | Position | Weight | As of |
|---|---|---|---|---|
| Ray Dalio | Bridgewater Associates | $0M | 0.0% | 2026-06-30 |
From the most recent 13F on file. A 13F reports long US equity positions quarterly and in arrears — it is what a manager held on the report date, not what they hold today.
Methodology breakdown computing — it will appear here on its own.
Hims & Hers Health Inc - Ordinary Shares - Class A (HIMS) is currently considered halal (Sharia-compliant), per our secondary compliance provider (last assessed 2026-08-12). See the full ratio breakdown and business-activity screen below for the reasoning.
Computing the full ratio and business-activity breakdown for HIMS — this runs off the critical path so the page paints first. It will appear here on its own.
Pinch or scroll to zoom · drag to pan — both axes move · double-click to reset
Classic floor-trader pivots from the last completed daily bar. Highlighted pills are the levels bracketing the current price.
The range is measured volatility (ATR over the horizon), not a target — a wider band means a more volatile asset, not a stronger view. The direction is the indicator tally above. Every forecast is recorded when made and scored against the real price when it comes due, including the wrong ones. Not a recommendation, and not a fatwa.
| Indicator | Value | Signal |
|---|---|---|
| RSI (14) | 42.80 | NEUTRAL |
| Stochastic %K (14) | 4.35 | BUY |
| CCI (20) | -95.62 | NEUTRAL |
| Williams %R (14) | -95.65 | BUY |
| MACD (12,26,9) | -0.23 | SELL |
| ROC (10) | -8.01 | SELL |
| Momentum (10) | -2.39 | SELL |
| EMA (10) | 28.51 | SELL |
| SMA (10) | 28.62 | SELL |
| EMA (20) | 29.22 | SELL |
| SMA (20) | 29.43 | SELL |
| EMA (30) | 29.64 | SELL |
| SMA (30) | 29.72 | SELL |
| EMA (50) | 29.90 | SELL |
| SMA (50) | 31.24 | SELL |
| EMA (100) | 29.84 | SELL |
| SMA (100) | 29.66 | SELL |
| EMA (200) | 32.15 | SELL |
| SMA (200) | 28.27 | SELL |
Standard indicator thresholds (RSI 30/70, Stochastic 20/80, CCI ±100, Williams %R −80/−20, MACD histogram sign, price vs. average) computed on daily bars. A summary of what common indicators say — not a recommendation, and not this site's own trading verdict.
Healthcare · Drug Manufacturers - Specialty & Generic
Hims & Hers Health, Inc. operates as a consumer-first health and wellness platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, Germany, the Republic of Ireland, France, Spain, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides personalized health and wellness products; over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, skincare, sexual health and wellness, and hair care under the Hims & Hers brand name; and laboratory testing services to measure a set of biomarkers. Additionally, it offers medical consultation, post-consultation support services, and delivery of laboratory testing results services. Further, the company provides treatments and products for various chronic conditions related to hormone health, weight loss, dermatology, and mental health. The company offers its products through retail partnerships, in stores, and online. Hims & Hers Health, Inc. is based in San Francisco, California.
Background via Yahoo Finance — informational, not part of the verdict.
🔴 AVOID
The main driver: lagging the market by 7.0%, insider selling on the open market. Too many signals pointing the wrong way. Wait for the picture to improve before committing capital.
Scores: 1 bullish / 3 bearish
Weak — low conviction, small size or skip
| Timeframe | Bias | Bars |
|---|---|---|
| 📅 Daily | BEARISH | 62 |
| ⏰ 4H | RANGING | 77 |
| 🕐 1H | RANGING | 98 |
| ⏱ 15-Min | BEARISH | 130 |
| ⏲ 5-Min | RANGING | 234 |
Peer movement computing — it will appear here on its own.
CLUSTER SELL 0 buys · 4 sells
Recent: Okupe Oluyemi sold 284321 sh @ $36.49 (2026-07-06); Okupe Oluyemi sold 284321 sh @ $34.03 (2026-06-22); Okupe Oluyemi sold 284321 sh @ $31.99 (2026-07-17)
NEUTRAL report date 2026-09-01 · Asset managers net 934180 (-19048)
Plain-language summary of the evidence already on this page — the Sharia screen, structure, momentum, and order flow above. It explains the read; it doesn't make the call. Generated on demand (a live AI call), never run automatically.